REVIEW
|
doi:10.20944/preprints202403.0902.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
NSCLC; lung cancer; gut microbiota; immunotherapy; immune checkpoint inhibitors
Online: 15 March 2024 (07:33:31 CET)